Clobazam (Psy and Mixed indications) updated on 02-10-2025

Microcephaly / Small head circumference for gestational age

R analysis
id Study   Lib. in paper Exposition period    Study type  Control type 
 
Tags OR 95%CI x1/n1 x0/n0 no cases no exposed ROB Ref.
S17716
R74726
Christensen (Indications other than epilepsy), 2024 Microcephaly (z-score for head circumference ≤3rd percentile for gestational week, sex, and country (including newborns with congenital malformations)) during pregnancy (anytime or not specified) population based cohort retrospective unexposed (general population or NOS) Adjustment: No BZD Coexposure: No (among antiseizure medications) Indication BZD: Psychiatric diseases (depression, anxiety, ...) 0.98 [0.06;16.34] C 0/17   133,324/4,445,621 133,324 17
ref
Total 1 studies 0.98 [0.06;16.34] 133,324 17
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives

Forest plot

StudyTE95% CIn casesn exposedweightROBABCDEF Christensen (Indications other than epilepsy), 2024Christensen, 2024 1 0.98[0.06; 16.34]133,324170%ROB confusion: criticalROB selection: lowROB classification: criticalROB missing: lowROB mesure: moderateROB reporting: moderate0.22.01.0ROB: A: confusion, B: selection, C: classification, D: missing, E: measurement, F: reportinglow,moderate,serious,critical,unclear,

1: Indications other than epilepsy;

Sensitivity analysis

SubsetTE95% CIn casesn exposedkI2 Type of studies cohort studiescohort studies 0.98[0.06; 16.34]133,32417 -NAChristensen (Indications other than epilepsy), 2024 1 case control studiescase control studies 0 Type of controls unexposed (disease free or unspecified)unexposed (disease free or unspecified) 0.98[0.06; 16.34]133,32417 -NAChristensen (Indications other than epilepsy), 2024 1 Tags Adjustment   - No  - No 0.98[0.06; 16.34]133,32417 -NAChristensen (Indications other than epilepsy), 2024 1 BZD Coexposure   - No (among antiseizure medications)  - No (among antiseizure medications) 0.98[0.06; 16.34]133,32417 -NAChristensen (Indications other than epilepsy), 2024 1 Indication BZD   - Psychiatric diseases (depression, a ...  - Psychiatric diseases (depression, anxiety, ...) 0.98[0.06; 16.34]133,32417 -NAChristensen (Indications other than epilepsy), 2024 1 All studiesAll studies 0.98[0.06; 16.34]133,32417 -NAChristensen (Indications other than epilepsy), 2024 10.210.01.0

Publication bias and p-hacking diagnosis

funnel plot

Funnel plot not drawn. Less than 3 points.

Asymetry test p-value = NaN (by Egger's regression)

not enought points

p values plot

Funnel plot not drawn. Less than 3 points.

Sub-groups analysis using all included studies

excluded

Sub-groupsTE95% CIn casesn exposedkI2ROB type of controls unexposed controls (disease free or unspecified)unexposed controls (disease free or unspecified) 0.98[0.06; 16.34]133,32417 -NAChristensen (Indications other than epilepsy), 2024 10.510.01.0